Option Care Health (NASDAQ:OPCH) Stock Rating Upgraded by Bank of America

Option Care Health (NASDAQ:OPCH) was upgraded by equities researchers at Bank of America from a “neutral” rating to a “buy” rating in a report released on Monday, Marketbeat reports. The brokerage presently has a $33.00 target price on the stock, up from their prior target price of $26.00. Bank of America‘s target price points to a potential upside of 14.90% from the stock’s current price.

OPCH has been the topic of a number of other research reports. UBS Group assumed coverage on shares of Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective on the stock. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their price target for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Barrington Research cut their price objective on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday, October 31st. JMP Securities reiterated a “market outperform” rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Finally, Truist Financial reduced their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $29.86.

Option Care Health Price Performance

OPCH opened at $28.72 on Monday. The stock has a market cap of $4.89 billion, a P/E ratio of 24.13, a P/E/G ratio of 2.43 and a beta of 1.31. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company has a fifty day simple moving average of $23.33 and a 200 day simple moving average of $27.70. Option Care Health has a 12 month low of $21.39 and a 12 month high of $34.63.

Insider Transactions at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the business’s stock in a transaction on Friday, November 8th. The shares were acquired at an average price of $22.54 per share, with a total value of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

A number of institutional investors have recently bought and sold shares of the stock. Westfield Capital Management Co. LP lifted its stake in shares of Option Care Health by 10.2% in the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after buying an additional 599,589 shares in the last quarter. Global Alpha Capital Management Ltd. boosted its stake in shares of Option Care Health by 108.3% during the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock worth $1,559,000 after acquiring an additional 25,905 shares during the last quarter. Victory Capital Management Inc. increased its position in Option Care Health by 4,432.8% in the third quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock worth $50,756,000 after buying an additional 1,585,818 shares in the last quarter. Graypoint LLC bought a new stake in Option Care Health during the 4th quarter worth approximately $1,161,000. Finally, Edgestream Partners L.P. lifted its stake in shares of Option Care Health by 96.8% during the 2nd quarter. Edgestream Partners L.P. now owns 351,476 shares of the company’s stock valued at $9,736,000 after buying an additional 172,845 shares in the last quarter. 98.05% of the stock is owned by institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.